Accuray ( (ARAY) ) has provided an announcement.
Accuray Inc. reported a strong start to fiscal 2025, with a focus on executing its strategic growth agenda. Despite a slight decline in total net revenue to $101.5 million compared to last year, the company remains optimistic, raising its fiscal guidance with expectations of $462-$472 million in total revenue and $28-$30 million in adjusted EBITDA. CEO Suzanne Winter highlighted robust performance in China and growing interest in the Accuray Tomo® C System, underscoring the company’s strategic position in the global radiotherapy market.
See more data about ARAY stock on TipRanks’ Stock Analysis page.
